| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycosylceramide flippase activity | 4.17e-05 | 3 | 75 | 2 | GO:0140351 | |
| GeneOntologyBiologicalProcess | microvillus assembly | 2.77e-06 | 28 | 73 | 4 | GO:0030033 | |
| GeneOntologyBiologicalProcess | microvillus organization | 6.18e-06 | 34 | 73 | 4 | GO:0032528 | |
| Domain | CNH | 2.02e-05 | 14 | 73 | 3 | SM00036 | |
| Domain | CNH | 2.52e-05 | 15 | 73 | 3 | PF00780 | |
| Domain | CNH | 2.52e-05 | 15 | 73 | 3 | PS50219 | |
| Domain | CNH_dom | 2.52e-05 | 15 | 73 | 3 | IPR001180 | |
| Domain | IGv | 2.12e-04 | 75 | 73 | 4 | SM00406 | |
| Domain | PROTEIN_KINASE_ATP | 4.16e-04 | 459 | 73 | 8 | PS00107 | |
| Domain | Prot_kinase_dom | 6.31e-04 | 489 | 73 | 8 | IPR000719 | |
| Domain | Hydrolase_3 | 6.64e-04 | 10 | 73 | 2 | PF08282 | |
| Domain | PROTEIN_KINASE_DOM | 6.65e-04 | 493 | 73 | 8 | PS50011 | |
| Domain | Protein_kinase_ATP_BS | 6.91e-04 | 379 | 73 | 7 | IPR017441 | |
| Domain | V-set | 7.68e-04 | 184 | 73 | 5 | PF07686 | |
| Domain | Tyr_kinase_rcpt_2_CS | 8.10e-04 | 11 | 73 | 2 | IPR002011 | |
| Domain | RECEPTOR_TYR_KIN_II | 9.70e-04 | 12 | 73 | 2 | PS00239 | |
| Domain | Ig_V-set | 1.09e-03 | 199 | 73 | 5 | IPR013106 | |
| Domain | Kinase-like_dom | 1.23e-03 | 542 | 73 | 8 | IPR011009 | |
| Domain | P_typ_ATPase_c | 1.33e-03 | 14 | 73 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 1.33e-03 | 14 | 73 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 1.33e-03 | 14 | 73 | 2 | IPR006539 | |
| Domain | PhoLip_ATPase_C | 1.33e-03 | 14 | 73 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 1.33e-03 | 14 | 73 | 2 | PF16209 | |
| Domain | Ser/Thr_kinase_AS | 2.71e-03 | 357 | 73 | 6 | IPR008271 | |
| Domain | S_TKc | 2.79e-03 | 359 | 73 | 6 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 2.91e-03 | 362 | 73 | 6 | PS00108 | |
| Domain | Pkinase | 3.74e-03 | 381 | 73 | 6 | PF00069 | |
| Domain | IG | 6.04e-03 | 421 | 73 | 6 | SM00409 | |
| Domain | Ig_sub | 6.04e-03 | 421 | 73 | 6 | IPR003599 | |
| Domain | - | 6.93e-03 | 32 | 73 | 2 | 3.40.1110.10 | |
| Domain | - | 6.93e-03 | 32 | 73 | 2 | 2.70.150.10 | |
| Pathway | REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS | 1.21e-05 | 12 | 55 | 3 | M27738 | |
| Pathway | WP_HIPPOYAP_SIGNALING | 8.21e-05 | 22 | 55 | 3 | M39821 | |
| Pubmed | 9.63e-09 | 3 | 75 | 3 | 22767497 | ||
| Pubmed | Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2. | 3.85e-08 | 4 | 75 | 3 | 39142074 | |
| Pubmed | 9.60e-08 | 5 | 75 | 3 | 29339503 | ||
| Pubmed | The cluster of BTN genes in the extended major histocompatibility complex. | 3.35e-07 | 7 | 75 | 3 | 11170752 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PPP1R26 STK10 SDSL TNRC18 EIF4ENIF1 TLN1 EIF2B3 LTK ARHGEF11 BIRC6 BTN3A2 CABLES1 THAP11 | 6.39e-07 | 1105 | 75 | 13 | 35748872 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TNIK STK10 AHCYL1 TRAFD1 EIF4ENIF1 JADE3 MAP3K8 EIF2B3 SIK2 XPA MAP4K4 PDLIM5 | 2.17e-06 | 1038 | 75 | 12 | 26673895 |
| Pubmed | Rap2A links intestinal cell polarity to brush border formation. | 4.30e-06 | 15 | 75 | 3 | 22797597 | |
| Pubmed | Differential role for CD277 as a co-regulator of the immune signal in T and NK cells. | 4.59e-06 | 2 | 75 | 2 | 21918970 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 22846996 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 21113407 | ||
| Pubmed | A 1.1-Mb transcript map of the hereditary hemochromatosis locus. | 7.68e-06 | 18 | 75 | 3 | 9149941 | |
| Pubmed | MINK is a Rap2 effector for phosphorylation of the postsynaptic scaffold protein TANC1. | 1.37e-05 | 3 | 75 | 2 | 18930710 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | 1.75e-05 | 377 | 75 | 7 | 38117590 | |
| Pubmed | 1.77e-05 | 251 | 75 | 6 | 29778605 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | SF3B3 TRAFD1 EIF4ENIF1 RADX EIF2B3 STYXL2 VPS53 CLUH RUSF1 MOV10 PPP4R3A THAP11 | 2.45e-05 | 1321 | 75 | 12 | 27173435 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 2.58e-05 | 724 | 75 | 9 | 36232890 | |
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 9382921 | ||
| Pubmed | 2.84e-05 | 733 | 75 | 9 | 34672954 | ||
| Pubmed | BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation. | 6.84e-05 | 6 | 75 | 2 | 20208008 | |
| Pubmed | NIK and Cot cooperate to trigger NF-kappaB p65 phosphorylation. | 6.84e-05 | 6 | 75 | 2 | 18439422 | |
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 25947375 | ||
| Pubmed | 9.53e-05 | 493 | 75 | 7 | 15368895 | ||
| Pubmed | MAP4K Interactome Reveals STRN4 as a Key STRIPAK Complex Component in Hippo Pathway Regulation. | 1.07e-04 | 216 | 75 | 5 | 32640226 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 1.48e-04 | 910 | 75 | 9 | 36736316 | |
| Pubmed | A secreted protein microarray platform for extracellular protein interaction discovery. | 1.86e-04 | 51 | 75 | 3 | 21982860 | |
| Pubmed | 1.96e-04 | 246 | 75 | 5 | 15345747 | ||
| Pubmed | 2.33e-04 | 401 | 75 | 6 | 25852190 | ||
| Pubmed | Common variants on chromosome 6p22.1 are associated with schizophrenia. | 2.49e-04 | 11 | 75 | 2 | 19571809 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.63e-04 | 774 | 75 | 8 | 15302935 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | AHCYL1 UBE2O HGH1 ZPR1 TLN1 EIF2B3 GBP1 BIRC6 CLUH PDLIM5 PPP4R3A | 2.77e-04 | 1455 | 75 | 11 | 22863883 |
| Pubmed | 2.99e-04 | 12 | 75 | 2 | 35027733 | ||
| Pubmed | 2.99e-04 | 12 | 75 | 2 | 21914794 | ||
| Pubmed | 3.02e-04 | 421 | 75 | 6 | 36976175 | ||
| Pubmed | TNIK AHCYL1 UBE2O SF3B3 TLN1 MINK1 SIK2 GATB ALAS1 MAP4K4 CLUH | 3.33e-04 | 1487 | 75 | 11 | 33957083 | |
| Pubmed | 4.11e-04 | 14 | 75 | 2 | 9151674 | ||
| Pubmed | 4.11e-04 | 14 | 75 | 2 | 19850283 | ||
| Pubmed | 5.82e-04 | 176 | 75 | 4 | 28692057 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 6.10e-04 | 670 | 75 | 7 | 22990118 | |
| Pubmed | 6.52e-04 | 78 | 75 | 3 | 17192257 | ||
| Pubmed | 7.19e-04 | 689 | 75 | 7 | 36543142 | ||
| Pubmed | 7.60e-04 | 189 | 75 | 4 | 31594818 | ||
| Pubmed | 7.66e-04 | 19 | 75 | 2 | 19767753 | ||
| Pubmed | 8.50e-04 | 20 | 75 | 2 | 20564319 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 9.01e-04 | 344 | 75 | 5 | 30333137 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 9.56e-04 | 942 | 75 | 8 | 31073040 | |
| Pubmed | 1.13e-03 | 23 | 75 | 2 | 29742433 | ||
| Pubmed | 1.23e-03 | 24 | 75 | 2 | 25240745 | ||
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 1.27e-03 | 372 | 75 | 5 | 22939624 | |
| Pubmed | HIRA Is Required for Heart Development and Directly Regulates Tnni2 and Tnnt3. | 1.33e-03 | 25 | 75 | 2 | 27518902 | |
| Pubmed | EIF4ENIF1 KDM5A TLN1 MINK1 ELAPOR1 CDC42EP5 FAM83D ATP1B1 ARHGEF11 MOV10 | 1.38e-03 | 1497 | 75 | 10 | 31527615 | |
| Pubmed | 1.42e-03 | 102 | 75 | 3 | 9734811 | ||
| Pubmed | 1.45e-03 | 225 | 75 | 4 | 12168954 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 1.45e-03 | 569 | 75 | 6 | 30639242 | |
| Pubmed | 1.63e-03 | 107 | 75 | 3 | 30995489 | ||
| Pubmed | 1.63e-03 | 794 | 75 | 7 | 11076863 | ||
| Pubmed | Ankyrin repeats of ANKRA2 recognize a PxLPxL motif on the 3M syndrome protein CCDC8. | 1.67e-03 | 28 | 75 | 2 | 25752541 | |
| Pubmed | Phosphoproteomics screen reveals akt isoform-specific signals linking RNA processing to lung cancer. | 1.67e-03 | 28 | 75 | 2 | 24462114 | |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 1.70e-03 | 235 | 75 | 4 | 28378594 | |
| Pubmed | Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131. | 1.76e-03 | 110 | 75 | 3 | 26841866 | |
| Pubmed | 1.79e-03 | 29 | 75 | 2 | 15071553 | ||
| Pubmed | 1.89e-03 | 242 | 75 | 4 | 34011540 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p13 | 4.08e-04 | 211 | 75 | 4 | chr1p13 | |
| Cytoband | 1p13.2 | 2.60e-03 | 46 | 75 | 2 | 1p13.2 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 4.83e-06 | 15 | 41 | 3 | 458 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.23e-05 | 163 | 41 | 5 | 590 | |
| GeneFamily | ATPase phospholipid transporting | 5.17e-04 | 15 | 41 | 2 | 1210 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 3.71e-03 | 40 | 41 | 2 | 321 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN | 2.31e-05 | 199 | 75 | 6 | M7645 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN | 2.31e-05 | 199 | 75 | 6 | M9595 | |
| Coexpression | GSE22886_CTRL_VS_LPS_24H_DC_DN | 2.38e-05 | 200 | 75 | 6 | M4520 | |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP | 2.38e-05 | 200 | 75 | 6 | M9598 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN | 2.38e-05 | 200 | 75 | 6 | M9576 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | STK10 BTN3A3 KDM5A MINK1 GBP1 XPA LY96 MAP4K4 BTN3A2 BTN3A1 ATP10D MOV10 NDFIP1 | 6.20e-05 | 1277 | 75 | 13 | MM1032 |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | 1.92e-04 | 417 | 75 | 7 | M2574 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN | 2.12e-04 | 189 | 75 | 5 | M8275 | |
| Coexpression | GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP | 2.17e-04 | 190 | 75 | 5 | M8021 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_STIMULATED | AHCYL1 EIF4ENIF1 KDM5A MINK1 GATB GBP1 XPA LY96 MAP4K4 ATP10D NDFIP1 | 2.26e-04 | 1072 | 75 | 11 | MM1031 |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN | 2.45e-04 | 195 | 75 | 5 | M7263 | |
| Coexpression | GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_UP | 2.51e-04 | 196 | 75 | 5 | M8157 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN | 2.51e-04 | 196 | 75 | 5 | M6129 | |
| Coexpression | GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_UP | 2.51e-04 | 196 | 75 | 5 | M6156 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | 2.52e-04 | 436 | 75 | 7 | MM1326 | |
| Coexpression | GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN | 2.57e-04 | 197 | 75 | 5 | M8227 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP | 2.57e-04 | 197 | 75 | 5 | M7543 | |
| Coexpression | GAUTAM_EYE_CORNEA_CONJUNCTIVAL_CELLS | 2.65e-04 | 108 | 75 | 4 | M43607 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN | 2.69e-04 | 199 | 75 | 5 | M4635 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN | 2.69e-04 | 199 | 75 | 5 | M8971 | |
| Coexpression | GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP | 2.69e-04 | 199 | 75 | 5 | M7655 | |
| Coexpression | GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN | 2.69e-04 | 199 | 75 | 5 | M6843 | |
| Coexpression | GSE11924_TH1_VS_TH17_CD4_TCELL_DN | 2.69e-04 | 199 | 75 | 5 | M3163 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 2.75e-04 | 200 | 75 | 5 | M9472 | |
| Coexpression | GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN | 2.75e-04 | 200 | 75 | 5 | M5124 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN | 2.75e-04 | 200 | 75 | 5 | M4632 | |
| Coexpression | GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_UP | 2.75e-04 | 200 | 75 | 5 | M6600 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_DN | 2.75e-04 | 200 | 75 | 5 | M9593 | |
| Coexpression | GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN | 2.75e-04 | 200 | 75 | 5 | M3416 | |
| Coexpression | GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN | 2.75e-04 | 200 | 75 | 5 | M3414 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_DN | 2.75e-04 | 200 | 75 | 5 | M3960 | |
| Coexpression | GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN | 2.75e-04 | 200 | 75 | 5 | M6095 | |
| Coexpression | GSE557_CIITA_KO_VS_I_AB_KO_DC_UP | 2.75e-04 | 200 | 75 | 5 | M6012 | |
| Coexpression | DESCARTES_ORGANOGENESIS_DEFINITIVE_ERYTHROID_LINEAGE | 3.13e-04 | 46 | 75 | 3 | MM3654 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 3.45e-04 | 210 | 75 | 5 | M2010 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 3.99e-08 | 195 | 75 | 7 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.13e-08 | 196 | 75 | 7 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.13e-08 | 196 | 75 | 7 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.13e-08 | 196 | 75 | 7 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.13e-08 | 196 | 75 | 7 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-gd_T|COVID-19_Severe / Disease, condition lineage and cell class | 4.74e-08 | 200 | 75 | 7 | f72bc3f6606ae77fe1b0a972e35b3ce0727804d9 | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.02e-06 | 197 | 75 | 6 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.02e-06 | 197 | 75 | 6 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | distal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.02e-06 | 197 | 75 | 6 | 3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.02e-06 | 197 | 75 | 6 | d4dfb3b561d0783cdbee4e8d27009ad81df695cb | |
| ToppCell | 21-Trachea-Epithelial-Club-like_secretory|Trachea / Age, Tissue, Lineage and Cell class | 1.05e-06 | 198 | 75 | 6 | e735d82e5151c98b5724c543f8ad633c8ed824d2 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.08e-06 | 199 | 75 | 6 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 | |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.08e-06 | 199 | 75 | 6 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.08e-06 | 199 | 75 | 6 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-06 | 199 | 75 | 6 | 1e693d7bb481bf03a943b460a69787229625d7b1 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-06 | 199 | 75 | 6 | 7d69785717073491b5fb81bf24db0175f86cd0b0 | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.01e-05 | 170 | 75 | 5 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-05 | 177 | 75 | 5 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-05 | 177 | 75 | 5 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.23e-05 | 177 | 75 | 5 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.23e-05 | 177 | 75 | 5 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.23e-05 | 177 | 75 | 5 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | ASK428-Immune-NK_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.33e-05 | 180 | 75 | 5 | 857d09446e3e6737e83d0f10bfda2ba282d5ba75 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.33e-05 | 180 | 75 | 5 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 1.44e-05 | 183 | 75 | 5 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-05 | 184 | 75 | 5 | c2ca984551baf4becbefbe58bd1889828542b045 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.52e-05 | 185 | 75 | 5 | b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-05 | 191 | 75 | 5 | cd709bbcd320373468ea7f058ee5fda8a067b5d0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-05 | 191 | 75 | 5 | 14851529025cfc2b665f71ebad04150ec543da7a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-05 | 191 | 75 | 5 | e14b22e882ac92acf8c8b6ee997ef8e799c7a8d5 | |
| ToppCell | BAL-Mild|BAL / Compartment, Disease Groups and Clusters | 1.82e-05 | 192 | 75 | 5 | 1a6cbf014d3f7a3fb6f53adab078c4742e7137de | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.87e-05 | 193 | 75 | 5 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.87e-05 | 193 | 75 | 5 | 605fc2a25ed6846fb283b2918cfed98df6039d6b | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.87e-05 | 193 | 75 | 5 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | CF-Epithelial|CF / Disease state, Lineage and Cell class | 1.87e-05 | 193 | 75 | 5 | 518901c2e36a79c6189cd0d9e6d36dbd4f56a79c | |
| ToppCell | CF-Epithelial-Epithelial_cell|CF / Disease state, Lineage and Cell class | 1.87e-05 | 193 | 75 | 5 | 4e3dda27c71b7fdac90d081f0d8e9ca3a8ea7820 | |
| ToppCell | Mild_COVID-19|World / Disease group,lineage and cell class (2021.01.30) | 1.87e-05 | 193 | 75 | 5 | 325b0768827bf8701bfb7f686bb11fd8b1a41a5c | |
| ToppCell | CD8+_Memory_T_cell-CV-6|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.91e-05 | 194 | 75 | 5 | 35a347c3824757b9de8b7f49db46e73e7fb63a4f | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.91e-05 | 194 | 75 | 5 | d0fb1ff5cf0738881e114a58f0b27489f781d72b | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.91e-05 | 194 | 75 | 5 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.91e-05 | 194 | 75 | 5 | 52e09b14159b609af00264a8f38accf37ba8f464 | |
| ToppCell | Nasal_Brush|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.96e-05 | 195 | 75 | 5 | 7509b980b6b293df02bec619ef5b83a6c7b49c03 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.96e-05 | 195 | 75 | 5 | d7e92bcbd05b93e86a1e1397e44ad27a9e2e637a | |
| ToppCell | T_cells-GZMK+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.96e-05 | 195 | 75 | 5 | 003ea7ddec6c1c98d2f6470bb51ebd97450eb936 | |
| ToppCell | Goblet_1|World / shred by cell class for nasal brushing | 1.96e-05 | 195 | 75 | 5 | d9e4889a2e7b7c97c07c15b043b77837739462e4 | |
| ToppCell | BAL-Mild|BAL / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.01e-05 | 196 | 75 | 5 | 6566e6671257f7df4d3f375e84f0b292ab4bcde1 | |
| ToppCell | BAL-Mild|BAL / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 196 | 75 | 5 | 3408d561d29802fca9eff5c54ccf70818d240cea | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD8+_Memory_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.01e-05 | 196 | 75 | 5 | af00c31612e4fe068e5fccae05368edba46bbd20 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.01e-05 | 196 | 75 | 5 | 093fb240e72911dfd360aa6edf8ed2d611c78a1e | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.01e-05 | 196 | 75 | 5 | 91902e135c05d1214d915c8d8e6037929c2501b8 | |
| ToppCell | Mild|World / Disease group and Cell class | 2.01e-05 | 196 | 75 | 5 | 5e4ed4a5a437cfa002b92775992a791e27aa4c27 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.01e-05 | 196 | 75 | 5 | c06caba0c91b8ee66f42bc43ec75eb2475f07056 | |
| ToppCell | (1)_T_cells-(1)_T_CD8_CytT|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.01e-05 | 196 | 75 | 5 | 3a4ba9ca84ce6b35038765da8c55812587b58bc2 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.01e-05 | 196 | 75 | 5 | 47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.01e-05 | 196 | 75 | 5 | 057d150bdf0cad959fd03ec2d1560a96ba03fae9 | |
| ToppCell | T_cells-CTLs|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 2.06e-05 | 197 | 75 | 5 | 28117cf300e169182571fbad0de1681a484a435a | |
| ToppCell | distal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.06e-05 | 197 | 75 | 5 | a00784ccfb1de6a96b91e2a8a2889b69f31a33da | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-05 | 197 | 75 | 5 | 9ae6d987e65972e1fb21aa407788d5e3ff41ad64 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.06e-05 | 197 | 75 | 5 | c0250509836f1be04f5e54386191d7bb1e1da652 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.06e-05 | 197 | 75 | 5 | 3f5dfa892a1f631b96eeb6f4cfc284aee51d1ce6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-05 | 197 | 75 | 5 | adb4e27d73ae2e6a39d212c0ead3ac0ad62d9131 | |
| ToppCell | T_cells-CTLs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 2.06e-05 | 197 | 75 | 5 | 2de34e20915a247bee75aa40495e23c20bb23e18 | |
| ToppCell | proximal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.11e-05 | 198 | 75 | 5 | 3477202c4f702d8f75231b13d4b5216f56d981d7 | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.11e-05 | 198 | 75 | 5 | 1e43181c13e054570046c7a973ddc1c586e259b0 | |
| ToppCell | proximal-Epithelial-Goblet|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.11e-05 | 198 | 75 | 5 | e7e1c430486a81280abc4a7e7f5bc3713dd20737 | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5AC+_High|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.11e-05 | 198 | 75 | 5 | 30e6177e216f66caddcd009fafef0e07369f4d8e | |
| ToppCell | proximal-Epithelial-Goblet-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.11e-05 | 198 | 75 | 5 | da7b40eb00bb5e454e1cfcd1219dc0d84712592a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-05 | 199 | 75 | 5 | 73704e8d774b3d08a311f69137972b07015c38f6 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-05 | 199 | 75 | 5 | 8bf8d7cd774479f065bbbbcb5a4bd1aa91aa0d85 | |
| ToppCell | (1)_T_cell-(10)_CD8_T|(1)_T_cell / shred on Cell_type and subtype | 2.16e-05 | 199 | 75 | 5 | d04896156e9ef6dda5f4f69fefdc7038c617d969 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-05 | 199 | 75 | 5 | 0c060ef64341659f4b1247d0264ac12e53a7e12e | |
| ToppCell | Biopsy_IPF-Epithelial-MUC5AC+_High|Biopsy_IPF / Sample group, Lineage and Cell type | 2.16e-05 | 199 | 75 | 5 | 51cb306e36537a53968c55187bd87c83e1706187 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD8+_Tem|Control / Disease, condition lineage and cell class | 2.21e-05 | 200 | 75 | 5 | fddb3df5b90eb97ef8ed80fac320c1a90903f012 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-05 | 200 | 75 | 5 | b68d212159b9d04866ba02ff55c35be247805eec | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.21e-05 | 200 | 75 | 5 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.21e-05 | 200 | 75 | 5 | 133853d0f55c63ebe94dd54151f9f1f90650a0d8 | |
| ToppCell | severe-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.21e-05 | 200 | 75 | 5 | d6767f06fe13be8110a86c2a6029be2dd9ce666c | |
| ToppCell | ileum-Absorptive_Enterocytes|ileum / shred on tissue and cell subclass | 4.53e-05 | 41 | 75 | 3 | 650cec538c6acd92f45d804b3c94248c6231aa21 | |
| ToppCell | Control-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.05e-04 | 145 | 75 | 4 | fe68582f5a15b9714cb84fa32ac880e13cb69895 | |
| ToppCell | Control-PLT_4|World / Disease Group and Platelet Clusters | 1.33e-04 | 154 | 75 | 4 | a2a03c5e6759c45aeeedf1e68ecb5a0112ef9a20 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-04 | 161 | 75 | 4 | c4970501c038ed36de447da70eabff020ad78713 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.58e-04 | 161 | 75 | 4 | 41a89a3d99a9bd6039a3d881d1d9dcd18bc07f25 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-04 | 161 | 75 | 4 | 1011094c54381d52566e24c92f89f2efc2aa3eea | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.65e-04 | 163 | 75 | 4 | 22fa5d017ff796394394d952ec151e2d1beb8248 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 166 | 75 | 4 | 0a7992bc673fca546636563ec3fc17a4298ab6b1 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.77e-04 | 166 | 75 | 4 | d16af6570806ed2880bd0efb5298932fd2a89cf5 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-04 | 167 | 75 | 4 | a90f905ef38437752e2b0b71bd0322a184de1861 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.85e-04 | 168 | 75 | 4 | 696b31bedbc7d40817a733e8c6ec2633404be619 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-SELL+_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.90e-04 | 169 | 75 | 4 | cc1b60eb50a274ffd72c67082c19e43af775e949 | |
| ToppCell | normal-na-Lymphocytic_B-B_plasma-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.94e-04 | 170 | 75 | 4 | c5b87974dfddf9780051f7f5693eeeb0c606a3fe | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.03e-04 | 172 | 75 | 4 | e9b97f37bb1732ad9aa89c5e9b513d14022801ac | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-04 | 172 | 75 | 4 | 965a9f62b73a7e3531c343121a7c507b7e1bfe05 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.03e-04 | 172 | 75 | 4 | fe3d0d8cb5f613ac2cfff450599698f1533a354f | |
| ToppCell | ASK454-Epithelial-Transformed_epithelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.03e-04 | 172 | 75 | 4 | 3986f0f098ef5e096c8d9ee3d335b8404083701f | |
| ToppCell | PND07-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.07e-04 | 173 | 75 | 4 | 28c98a9a54aa2cfa67464db4f628c9357ad185b9 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass | 2.12e-04 | 174 | 75 | 4 | 390bd41ef114464f3db3e0cac4e67fe7571b4c23 | |
| ToppCell | ASK452-Immune-NK_cell|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.12e-04 | 174 | 75 | 4 | b84e6dc1c003a677234ce3a818650ff58a45dd09 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.17e-04 | 175 | 75 | 4 | 97616bb5c127284aa9e67bc336dfcf29e137164b | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B1|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.17e-04 | 175 | 75 | 4 | b1003230c39b2a9ceb43cb80728061d906ed0835 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-04 | 176 | 75 | 4 | 76fdf211bce101e83a27d822cb399487bd107027 | |
| Computational | Neighborhood of CASP8 | 1.06e-05 | 27 | 56 | 4 | GNF2_CASP8 | |
| Computational | Neighborhood of SNRK | 1.23e-05 | 28 | 56 | 4 | GNF2_SNRK | |
| Computational | Neighborhood of ITGAL | 1.85e-04 | 55 | 56 | 4 | GNF2_ITGAL | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 2.80e-07 | 197 | 75 | 8 | 5499_UP | |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; PC3; HT_HG-U133A | 4.07e-06 | 198 | 75 | 7 | 4194_DN | |
| Drug | estradiol, USP; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 4.21e-06 | 199 | 75 | 7 | 1021_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 3.67e-05 | 188 | 75 | 6 | 1306_UP | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; PC3; HT_HG-U133A | 4.01e-05 | 191 | 75 | 6 | 7376_DN | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; PC3; HT_HG-U133A | 4.25e-05 | 193 | 75 | 6 | 4226_DN | |
| Drug | Cefalonium [5575-21-3]; Down 200; 8.8uM; PC3; HT_HG-U133A | 4.25e-05 | 193 | 75 | 6 | 4245_DN | |
| Drug | Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; HL60; HT_HG-U133A | 4.63e-05 | 196 | 75 | 6 | 2339_UP | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 4.77e-05 | 197 | 75 | 6 | 3617_UP | |
| Drug | Sulmazole [73384-60-8]; Down 200; 14uM; PC3; HT_HG-U133A | 4.77e-05 | 197 | 75 | 6 | 4009_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; PC3; HT_HG-U133A | 4.77e-05 | 197 | 75 | 6 | 7504_DN | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | 4.77e-05 | 197 | 75 | 6 | 7309_DN | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Down 200; 9.4uM; PC3; HT_HG-U133A | 4.90e-05 | 198 | 75 | 6 | 7384_DN | |
| Drug | Sulfisoxazole [127-69-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 4.90e-05 | 198 | 75 | 6 | 3218_UP | |
| Drug | Tyloxapol [25301-02-4]; Down 200; 4uM; HL60; HT_HG-U133A | 5.04e-05 | 199 | 75 | 6 | 3074_DN | |
| Disease | progressive familial intrahepatic cholestasis (implicated_via_orthology) | 1.71e-05 | 3 | 71 | 2 | DOID:0070221 (implicated_via_orthology) | |
| Disease | glucose metabolism decline measurement, cingulate cortex measurement | 2.03e-04 | 9 | 71 | 2 | EFO_0007738, EFO_0009392 | |
| Disease | epilepsy (implicated_via_orthology) | 6.54e-04 | 163 | 71 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | developmental dysplasia of the hip | 6.70e-04 | 16 | 71 | 2 | EFO_1000648 | |
| Disease | decreased susceptibility to hepatitis C infection | 6.70e-04 | 16 | 71 | 2 | EFO_0010101 | |
| Disease | age of onset of asthma | 9.26e-04 | 79 | 71 | 3 | OBA_2001001 | |
| Disease | triacylglycerol 48:2 measurement | 1.28e-03 | 22 | 71 | 2 | EFO_0010405 | |
| Disease | Tinnitus, wellbeing measurement | 1.63e-03 | 96 | 71 | 3 | EFO_0007869, HP_0000360 | |
| Disease | Inhalant adrenergic use measurement | 1.63e-03 | 96 | 71 | 3 | EFO_0009941 | |
| Disease | corpus callosum volume measurement | 1.83e-03 | 100 | 71 | 3 | EFO_0010299 | |
| Disease | triacylglycerol 50:2 measurement | 2.54e-03 | 31 | 71 | 2 | EFO_0010409 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TLDAEPMLAGCVARV | 666 | Q8N944 | |
| LNMPLSEVCEGFDEE | 41 | Q9NTU4 | |
| AQRDDMIFEDCGDVP | 116 | P05026 | |
| LAGELLAPVAAEAME | 2416 | Q9NR09 | |
| LAMVGEDADLPCHLF | 41 | O00478 | |
| LAMVGEDADLPCHLF | 41 | O00481 | |
| VDMPFATVDIQDDCG | 36 | Q9P0M2 | |
| MFQLAVDLPACEALG | 31 | Q9UKB5 | |
| DARGVLCEAQEAAMP | 396 | O15085 | |
| VLEPDMSCGEEAATA | 221 | O75879 | |
| LACIGDEMDVSLRAP | 61 | Q13323 | |
| ACCMELPAAAGDAVR | 21 | Q6ZP65 | |
| GADSVIMDLLEDPAC | 791 | O94823 | |
| ADMVLLFSTDPDGIC | 191 | Q9P241 | |
| EDLLADFEGPSIMDC | 471 | Q96DU7 | |
| IEHMICDTDPELGGA | 431 | Q6IN85 | |
| LDDMPENCICDVIGL | 366 | Q6NSI4 | |
| VLVDDMLPCDEAGCL | 596 | O75808 | |
| ITAIEMAEGAPPLCD | 221 | O95819 | |
| SMDGAVCPLEELCDV | 386 | P13196 | |
| AMLDEECLRPGVVSD | 451 | Q9UBC5 | |
| PAADSCAIMEGEDVE | 956 | Q6UXG2 | |
| ADPAVGDMVQLLCEA | 216 | Q6DN72 | |
| EDIADDCSPGMRELI | 351 | P41279 | |
| QLAECLCPEGMELAV | 396 | P29376 | |
| MALLSEGLDEVPAAC | 1 | Q9H4H8 | |
| AVIAALAICGIEMDE | 56 | Q8N8W4 | |
| SGDLPCMENAVLALA | 306 | P32455 | |
| CEFPIEAGDMFLEAL | 541 | Q96HC4 | |
| LIFKMAADPECLDVG | 616 | P29375 | |
| AADPECLDVGLAAMV | 621 | P29375 | |
| MALALAALAAVEPAC | 1 | Q9BT67 | |
| VCIPDDADMGTADSL | 76 | Q9NR50 | |
| LCDVTLMPGDTDDAF | 91 | Q9P2N7 | |
| LAQEDCGLEEPTVAM | 526 | Q8TDN4 | |
| CEGDLAEAMPALEAA | 2756 | Q8TD57 | |
| AEAMPALEAALAALD | 2761 | Q8TD57 | |
| LAMVGEDADLPCHLF | 41 | P78410 | |
| DAVLGVMDAARPEAA | 101 | Q6NZY7 | |
| EAISGSPEEMLFCLE | 136 | Q9Y6Y9 | |
| VHDMAECIVGDIAPA | 76 | Q7Z4H3 | |
| DCDNMRVTAFLDIPG | 26 | Q9P1A2 | |
| LNEDLAEMGCGPVDE | 151 | Q92613 | |
| APCAALMAALAAAEP | 136 | Q9BTY7 | |
| ITAIEMAEGAPPLCD | 221 | Q8N4C8 | |
| EMVPGAADCNITADS | 96 | Q11128 | |
| CIITVEGAALDPDDM | 711 | Q9P2B2 | |
| MADDAGLETPLCSEQ | 1 | Q96GQ5 | |
| TEEGEFMACSPVALD | 21 | P35716 | |
| DIKGAADEIMLPCEF | 281 | O14545 | |
| EAGHCMEPESLVAIA | 646 | Q9HCE1 | |
| EIDPICALQACMDGF | 341 | O43865 | |
| SELPGLFDCEMLDAV | 901 | Q9H0K1 | |
| LAVCGLVADFDPMGE | 96 | Q5T8A7 | |
| LLVMQPCAGQDEAAA | 46 | O00287 | |
| ALFAEAACPEGQAME | 221 | Q9BRJ9 | |
| DDERMLVEPACGAAL | 266 | Q96GA7 | |
| VPCLASMIEDVLGEG | 316 | Q9NRA8 | |
| DCMEHAVLPVDGATL | 761 | O75153 | |
| AMELAVECSFPVGEG | 361 | Q6UXD7 | |
| EDPLAGMNALAAAAE | 1336 | O15417 | |
| CSVEIPELEFELGMA | 331 | O75312 | |
| ITAIEMAEGAPPLCD | 221 | Q9UKE5 | |
| DPEEMAEDCNGAGLV | 446 | P17040 | |
| GLQSMSAPCVEADDA | 91 | P08138 | |
| AQEACGPLEMDSALS | 1041 | Q9Y490 | |
| RADAECPGMLESAEQ | 76 | Q5VZP5 | |
| CPGMLESAEQLLVED | 81 | Q5VZP5 | |
| PMLETDAEAGDSAQC | 376 | O94964 | |
| EFCPGGAVDAIMLEL | 111 | O94804 | |
| FRAALLEAGMPECTE | 1276 | Q9C0C9 | |
| EDGDVICLNSDDIMP | 2246 | P08922 | |
| RAAASVMCHIEPDDG | 106 | Q5JUR7 | |
| EGAADDPDSSMVLLC | 216 | Q9NQ25 | |
| NDLDDPERGMIFVCS | 276 | Q15393 | |
| VQDLDAACDPALTAM | 606 | Q5VIR6 | |
| MAAADGALPEAAALE | 1 | P23025 | |
| LQAATAGLEAAECPM | 211 | Q96EK4 | |
| GIGEAVCAAVSMDPD | 541 | P51854 |